R. De Cuia

Negative impact of FLT3 abnormalities in elderly acute myeloid leukemia patients

R. Latagliata, G. Cimino, A. Guarini, 2008, Leukemia & lymphoma.

"Real-life" results of front-line treatment with Imatinib in older patients (≥ 65 years) with newly diagnosed chronic myelogenous leukemia.

R. Latagliata, A. Frustaci, M. Mancini, 2010, Leukemia research.

Achievement of complete molecular responses in late chronic phase chronic myeloid leukaemia patients treated with pulsed imatinib while in minimal residual disease.

M. Breccia, G. Alimena, D. Diverio, 2009, Leukemia research.

Acute myeloid leukemia and lung cancer occurring in a chronic lymphocytic leukemia patient treated with fludarabine and autologous peripheral blood stem-cell transplantation.

F. Mandelli, E. Pescarmona, G. Meloni, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Isodicentric duplication of Philadelphia chromosome as a mechanism of resistance to dasatinib in a patient with chronic myeloid leukemia after resistance to imatinib

M. Mancini, M. Breccia, G. Alimena, 2011, Leukemia & lymphoma.

Elderly patients with Ph+ chronic myelogenous leukemia (CML): results of imatinib mesylate treatment.

F. Mandelli, R. Latagliata, M. Mancini, 2005, Leukemia research.